|
1
|
Ho YL, Wu CC, Lin LC, et al: Assessment of
the coronary artery disease and systolic dysfunction in
hypertensive patients with the dobutamine-atropine stress
echocardiography: effect of the left ventricular hypertrophy.
Cardiology. 89:52–58. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aaronson KD and Sackner-Bernstein J: Risk
of death associated with nesiritide in patients with acutely
decompensated heart failure. JAMA. 296:1465–1466. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Catalucci D, Latronico MV, Ellingsen O and
Condorelli G: Physiological myocardial hypertrophy: how and why.
Front Biosci. 13:312–324. 2008. View
Article : Google Scholar
|
|
4
|
Koren MJ, Devereux RB, Casale PN, Savage
DD and Laragh JH: Relation of left ventricular mass and geometry to
morbidity and mortality in uncomplicated essential hypertension.
Ann Intern Med. 114:345–352. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McKinsey TA and Kass DA: Small-molecule
therapies for cardiac hypertrophy: moving beneath the cell surface.
Nat Rev Drug Discov. 6:617–635. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP and Chen CZ: Micromanagers of
gene expression: the potentially widespread influence of metazoan
microRNAs. Nat Rev Genet. 5:396–400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Divakaran V and Mann DL: The emerging role
of microRNAs in cardiac remodeling and heart failure. Circ Res.
103:1072–1083. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Rooij E and Olson EN: MicroRNAs:
powerful new regulators of heart disease and provocative
therapeutic targets. J Clin Invest. 117:2369–2376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Rooij E: The art of microRNA research.
Circ Res. 108:219–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Rooij E, Marshall WS and Olson EN:
Toward microRNA-based therapeutics for heart disease: the sense in
antisense. Circ Res. 103:919–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Small EM, Frost RJ and Olson EN: MicroRNAs
add a new dimension to cardiovascular disease. Circulation.
121:1022–1032. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Care A, Catalucci D and Felicetti F:
MicroRNA-133 controls cardiac hypertrophy. Nat Med. 13:613–618.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
van Rooij E, Sutherland LB, Liu N, et al:
A signature pattern of stress-responsive microRNAs that can evoke
cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA.
103:18255–18260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van Rooij E, Sutherland LB, Qi X,
Richardson JA, Hill J and Olson EN: Control of stress-dependent
cardiac growth and gene expression by a microRNA. Science.
316:575–579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang B, Lin H and Xiao J: The
muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic
potential by targeting GJA1 and KCNJ2. Nat Med. 13:486–491. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thum T, Gross C and Fiedler J: MicroRNA-21
contributes to myocardial disease by stimulating MAP kinase
signalling in fibroblasts. Nature. 456:980–984. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Rooij E, Sutherland LB, Thatcher JE,
et al: Dysregulation of microRNAs after myocardial infarction
reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci
USA. 105:13027–13032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu S, Huang M and Li Z: MicroRNA-210 as a
novel therapy for treatment of ischemic heart disease. Circulation.
122:S124–S131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thum T, Galuppo P and Wolf C: MicroRNAs in
the human heart: A clue to fetal gene reprogramming in heart
failure. Circulation. 116:258–267. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA.org resource: targets and expression.
Nucleic Acids Res. 36:D149–D153. 2008. View Article : Google Scholar :
|
|
24
|
Papp S, Dziak E, Kabir G, Backx P, Clement
S and Opas M: Evidence for calreticulin attenuation of cardiac
hypertrophy induced by pressure overload and soluble agonists. Am J
Pathol. 176:1113–1121. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Creemers EE and Pinto YM: Molecular
mechanisms that control interstitial fibrosis in the
pressure-overloaded heart. Cardiovasc Res. 89:265–272. 2011.
View Article : Google Scholar
|
|
26
|
Duisters RF, Tijsen AJ, Schroen B, et al:
miR-133 and miR-30 regulate connective tissue growth factor:
implications for a role of microRNAs in myocardial matrix
remodeling. Circ Res. 104:170–178. 2009. View Article : Google Scholar
|
|
27
|
Condorelli G, Morisco C, Stassi G, et al:
Increased cardio-myocyte apoptosis and changes in proapoptotic and
antiapoptotic genes bax and bcl-2 during left ventricular
adaptations to chronic pressure overload in the rat. Circulation.
99:3071–3078. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Okada K, Minamino T and Tsukamoto Y:
Prolonged endoplasmic reticulum stress in hypertrophic and failing
heart after aortic constriction: possible contribution of
endoplasmic reticulum stress to cardiac myocyte apoptosis.
Circulation. 110:705–712. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brostrom MA, Mourad F and Brostrom CO:
Regulated expression of GRP78 during vasopressin-induced
hypertrophy of heart-derived myocytes. J Cell Biochem. 83:204–217.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee KH, Lee N, Lim S, et al: Calreticulin
inhibits the MEK1,2-ERK1,2 pathway in alpha 1-adrenergic
receptor/Gh-stimulated hypertrophy of neonatal rat cardiomyocytes.
J Steroid Biochem Mol Biol. 84:101–107. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu FF, Liu XH and Zhu XM: Calreticulin
upregulation induced by hypoxic preconditioning relieves oxidative
stress injury in rat cardiomyocytes. Sheng Li Xue Bao. 60:29–37.
2008.In Chinese. PubMed/NCBI
|
|
32
|
Liu XH: Endoplasmic reticulum stress and
myocardial hypertrophy. Sheng Li Xue Bao. 61:9–14. 2009.In Chinese.
PubMed/NCBI
|
|
33
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lim LP, Lau NC, Garrett-Engele P, et al:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Heineke J and Molkentin JD: Regulation of
cardiac hypertrophy by intracellular signalling pathways. Nat Rev
Mol Cell Biol. 7:589–600. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Glembotski CC: Endoplasmic reticulum
stress in the heart. Circ Res. 101:975–984. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kaufman RJ: Stress signaling from the
lumen of the endoplasmic reticulum: coordination of gene
transcriptional and translational controls. Genes Dev.
13:1211–1233. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Austin RC: The unfolded protein response
in health and disease. Antioxid Redox Signal. 11:2279–2287. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Glembotski CC: The role of the unfolded
protein response in the heart. J Mol Cell Cardiol. 44:453–459.
2008. View Article : Google Scholar
|
|
40
|
Kim I, Xu W and Reed JC: Cell death and
endoplasmic reticulum stress: disease relevance and therapeutic
opportunities. Nat Rev Drug Discov. 7:1013–1030. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu C, Bailly-Maitre B and Reed JC:
Endoplasmic reticulum stress: cell life and death decisions. J Clin
Invest. 115:2656–2664. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
John LM, Lechleiter JD and Camacho P:
Differential modulation of SERCA2 isoforms by calreticulin. J Cell
Biol. 142:963–973. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Camacho P and Lechleiter JD: Calreticulin
inhibits repetitive intracellular Ca2+ waves. Cell.
82:765–771. 1995. View Article : Google Scholar : PubMed/NCBI
|
